Last reviewed · How we verify
Chloroquine and sulphadoxine-pyrimethamine
Chloroquine and sulphadoxine-pyrimethamine is a Small molecule drug developed by Menzies School of Health Research. It is currently in Phase 1 development.
At a glance
| Generic name | Chloroquine and sulphadoxine-pyrimethamine |
|---|---|
| Sponsor | Menzies School of Health Research |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Preventing Malaria in School Children to Protect the Whole Community in Rural Blantyre District, Malawi (PHASE4)
- Efficacy and Safety of Sulphadoxine-pyrimethamine and Amodiaquine in Ghanaian Pregnant Women (PHASE3)
- Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan (PHASE3)
- Chemoprevention Efficacy Study in Burkina Faso (PHASE4)
- Comparing Chemoprevention Drugs for School-based Malaria Control (PHASE4)
- Chemoprevention Efficacy Study Nigeria (PHASE4)
- Dose Escalation PfSPZ-CVac (PHASE1)
- Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B... (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chloroquine and sulphadoxine-pyrimethamine CI brief — competitive landscape report
- Chloroquine and sulphadoxine-pyrimethamine updates RSS · CI watch RSS
- Menzies School of Health Research portfolio CI
Frequently asked questions about Chloroquine and sulphadoxine-pyrimethamine
What is Chloroquine and sulphadoxine-pyrimethamine?
Chloroquine and sulphadoxine-pyrimethamine is a Small molecule drug developed by Menzies School of Health Research.
Who makes Chloroquine and sulphadoxine-pyrimethamine?
Chloroquine and sulphadoxine-pyrimethamine is developed by Menzies School of Health Research (see full Menzies School of Health Research pipeline at /company/menzies-school-of-health-research).
What development phase is Chloroquine and sulphadoxine-pyrimethamine in?
Chloroquine and sulphadoxine-pyrimethamine is in Phase 1.